TrialBMC cancer2022

Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.

Naosuke Yokomichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.